...
首页> 外文期刊>Medizinische Klinik >Prekallikrein (Fletcher Factor) Deficiency and Prolongation of APTT Reaction
【24h】

Prekallikrein (Fletcher Factor) Deficiency and Prolongation of APTT Reaction

机译:前激肽释放酶(弗莱彻因子)的缺乏和APTT反应的延长

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Prekallikrein (Fletcher factor) is a protein of the contact phase of the blood coagulation system. A deficiency is a very rare event. The clinical meaning is still unknown. CASE REPORT: In a 24-year-old patient of Croatian nationality, who has never suffered from any kind of proneness to hemorrhage, a considerable prolongation of activated partial thromboplastin time (APTT) was diagnosed preoperatively. The prothrombin time (PT) was normal. The patient had to be subjected to horseshoe-kidney surgery. CLOTTING TESTS: A very seldom Fletcher factor (prekallikrein) deficiency type II was detected. The activity was < 1%, but the prekallikrein concentration was normal, comparable to that in normal plasma. THERAPY AND COURSE: Complications were neither noticed during renal surgery nor postoperatively. The patient did not show clinical symptoms. This fact corroborates reports about similar cases published earlier. CONCLUSION: Nevertheless, attention has to be paid to these exceptionally rare symptoms, as in some publications, thromboembolic or even bleeding complications were reported.
机译:背景:前激肽释放酶(弗莱彻因子)是凝血系统接触阶段的一种蛋白质。缺乏是非常罕见的事件。临床意义尚不清楚。病例报告:在一名24岁的克罗​​地亚国籍患者中,他从未经历过任何类型的出血倾向,术前确诊其激活的部分凝血活酶时间(APTT)明显延长。凝血酶原时间(PT)正常。该患者必须接受马蹄肾手术。凝结测试:很少发现II型Fletcher因子(前激肽释放酶)缺乏。活性<1%,但前激肽释放酶的浓度正常,与正常血浆中的浓度相当。治疗与课程:肾脏手术或手术后均未发现并发症。该患者未显示临床症状。这一事实证实了先前发表的有关类似案件的报道。结论:尽管如此,仍必须注意这些异常罕见的症状,如在某些出版物中报道了血栓栓塞甚至出血并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号